Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Nuclear Medicine and Biology

• Publication date

  2010-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.nucmedbio.2010.03.010PMID 20870153PMCID PMC2946889
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• GMab-1, a high-affinity anti-3'-isoLM1/3',6'-isoLD1 IgG monoclonal antibody, raised in lacto-series ganglioside-defective knockout mice.

  2010cited by this paper
• Tumorigenic Role of Podoplanin in Esophageal Squamous-Cell Carcinoma

  2010cited by this paper
• Low podoplanin expression of tumor cells predicts poor prognosis in pathological stage IB squamous cell carcinoma of the lung, tissue microarray analysis of 136 patients using 24 antibodies.

  2009cited by this paper
• Co-expression of Bmi-1 and podoplanin predicts overall survival in patients with squamous cell carcinoma of the head and neck treated with radio(chemo)therapy.

  2009cited by this paper
• Characterization of Anti-podoplanin Monoclonal Antibodies: Critical Epitopes for Neutralizing the Interaction Between Podoplanin and CLEC-2

  2008cited by this paper
• Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy.

  2008cited by this paper
• Podoplanin, a novel marker of tumor-initiating cells in human squamous cell carcinoma A431.

  2008cited by this paper
• Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma

  2008cited by this paper
• Induction of podoplanin by transforming growth factor‐β in human fibrosarcoma

  2008cited by this paper
• Induction of podoplanin by transforming growth factor-beta in human fibrosarcoma.

  2008cited by this paper
• Functional glycosylation of human podoplanin: Glycan structure of platelet aggregation‐inducing factor

  2007cited by this paper
• Tumorigenesis and Neoplastic Progression The Platelet Aggregation-Inducing Factor Aggrus / Podoplanin Promotes Pulmonary Metastasis

  2007cited by this paper
• Molecular analysis of the pathophysiological binding of the platelet aggregation‐inducing factor podoplanin to the C‐type lectin‐like receptor CLEC‐2

  2007cited by this paper
• Conservation of a platelet activating domain of Aggrus/podoplanin as a platelet aggregation-inducing factor.

  2006cited by this paper
• Low podoplanin expression in pretreatment biopsy material predicts poor prognosis in advanced-stage squamous cell carcinoma of the uterine cervix treated by primary radiation

  2006cited by this paper
• Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

  2006cited by this paper
• Radiation resistance and stem-like cells in brain tumors.

  2006cited by this paper
• Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition

  2006cited by this paper
• Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression

  2006cited by this paper
• Podoplanin expression in primary central nervous system germ cell tumors: a useful histological marker for the diagnosis of germinoma

  2006cited by this paper
• Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain.

  2006cited by this paper
• Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton.

  2006cited by this paper
• Characterization of human PA2.26 antigen (T1α–2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas

  2005cited by this paper
• Brain tumors

  2005cited by this paper
• Enhanced Expression of Aggrus (T1alpha/Podoplanin), a Platelet-Aggregation-Inducing Factor in Lung Squamous Cell Carcinoma

  2005cited by this paper
• Functional Sialylated O-Glycan to Platelet Aggregation on Aggrus (T1α/Podoplanin) Molecules Expressed in Chinese Hamster Ovary Cells*

  2004cited by this paper
• Identification of human brain tumour initiating cells

  2004cited by this paper
• Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors

  2004cited by this paper
• N-succinimidyl 3-[211At]astato-4-guanidinomethylbenzoate: an acylation agent for labeling internalizing antibodies with alpha-particle emitting 211At.

  2003cited by this paper
• Molecular Identification of Aggrus/T1α as a Platelet Aggregation-inducing Factor Expressed in Colorectal Tumors*

  2003cited by this paper
• Improved xenograft targeting of tumor-specific anti-epidermal growth factor receptor variant III antibody labeled using N-succinimidyl 4-guanidinomethyl-3-iodobenzoate.

  2002cited by this paper
• High-Level Production of α-Particle–Emitting 211At and Preparation of 211At-Labeled Antibodies for Clinical Use

  2001cited by this paper
• Brain tumors.

  2001cited by this paper
• A polar substituent-containing acylation agent for the radioiodination of internalizing monoclonal antibodies: N-succinimidyl 4-guanidinomethyl-3-[131I]iodobenzoate ([131I]SGMIB).

  2001influential reference
• High-level production of alpha-particle-emitting (211)At and preparation of (211)At-labeled antibodies for clinical use.

  2001cited by this paper
• Immunotoxins with increased activity against epidermal growth factor receptor vIII-expressing cells produced by antibody phage display.

  2000cited by this paper
• Targeting cancer micrometastases with monoclonal antibodies: a binding-site barrier.

  1995cited by this paper
• Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts.

  1995influential reference
• Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas.

  1995cited by this paper
• Occurrence of Lacto Series Gangliosides 3'-isoLM1 and 3',6'-isoLD1 in Human Gliomas in vitro and in vivo

  1991cited by this paper
• Monoclonal antibody and F(ab')2 fragment delivery to tumor in patients with glioma: comparison of intracarotid and intravenous administration.

  1990cited by this paper
• Pharmacokinetics and tumor localization of 131I-labeled anti-tenascin monoclonal antibody 81C6 in patients with gliomas and other intracranial malignancies.

  1989cited by this paper
• Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents.

  1988cited by this paper
• Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification.

  1987cited by this paper
• Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess.

  1984cited by this paper

• Antitumor Activities by a Humanized Cancer‐Specific Anti‐Podoplanin Monoclonal Antibody humPMab‐117 Against Human Tumors

  2025cites this paper
• Development of a Sensitive Anti-Mouse CD39 Monoclonal Antibody (C39Mab-1) for Flow Cytometry and Western Blot Analyses

  2024cites this paper
• Establishment of Anti-Dog Programmed Cell Death Ligand 1 Monoclonal Antibodies for Immunohistochemistry

  2024cites this paper
• A Rat Anti-Mouse CD39 Monoclonal Antibody for Flow Cytometry

  2023cites this paper
• EMab-300 Detects Mouse Epidermal Growth Factor Receptor-Expressing Cancer Cell Lines in Flow Cytometry

  2023cites this paper
• A Novel Anti-CD44 Variant 3 Monoclonal Antibody C44Mab-6 Was Established for Multiple Applications

  2023cites this paper
• Development of a Novel Anti-CD44 Variant 5 Monoclonal Antibody C44Mab-3 for Multiple Applications against Pancreatic Carcinomas

  2023cites this paper
• A Novel Anti-CD44 Variant 9 Monoclonal Antibody C44Mab-1 Was Developed for Immunohistochemical Analyses against Colorectal Cancers

  2023cites this paper
• Development of a Novel Anti-CD44 Variant 7/8 Monoclonal Antibody, C44Mab-34, for Multiple Applications against Oral Carcinomas

  2023cites this paper
• Development of a Novel Anti-CD44 Variant 4 Monoclonal Antibody C44Mab-108 for Immunohistochemistry

  2023cites this paper
• Development of a Novel Anti-CD44 Variant 6 Monoclonal Antibody C44Mab-9 for Multiple Applications against Colorectal Carcinomas

  2023cites this paper
• Epitope Mapping of an Anti-elephant Podoplanin Monoclonal Antibody (PMab-295) Using Enzyme-Linked Immunosorbent Assay

  2022cites this paper
• PDPN marks a subset of aggressive and radiation-resistant glioblastoma cells

  2022cites this paper
• Efficacy of cancer-specific anti-podoplanin CAR-T cells and oncolytic herpes virus G47Δ combination therapy against glioblastoma

  2022cites this paper
• Effect of Anti-Podoplanin on Malignant Glioma Cell Viability, Invasion and Tumor Cell-Induced Platelet Aggregation.

  2022cites this paper
• Roles of Podoplanin in Malignant Progression of Tumor

  2022cites this paper
• Development of a Monoclonal Antibody PMab-295 Against Elephant Podoplanin

  2022cites this paper
• Development of an Anti-Elephant Podoplanin Monoclonal Antibody PMab-265 for Flow Cytometry

  2021cites this paper
• Development of Monoclonal Antibody PMab-269 Against California Sea Lion Podoplanin

  2021cites this paper
• Crystal structure of an anti-podoplanin antibody bound to a disialylated O-linked glycopeptide.

  2020cites this paper
• Development of Core-Fucose-Deficient Humanized and Chimeric Anti-Human Podoplanin Antibodies

  2020cites this paper
• Detection of Circulating Tumor Cells (CTCs) in Malignant Pleural Mesothelioma (MPM) with the “Universal” CTC-Chip and An Anti-Podoplanin Antibody NZ-1.2

  2020cites this paper
• Epitope Mapping of Monoclonal Antibody PMab-233 Against Tasmanian Devil Podoplanin

  2019cites this paper
• Epitope Mapping of Antipig Podoplanin Monoclonal Antibody PMab-213

  2019cites this paper
• Characterization of Anti-Goat Podoplanin Monoclonal Antibody PMab-235 Using Immunohistochemistry Against Goat Tissues

  2019cites this paper
• Epitope Mapping of Anti-Tiger Podoplanin Monoclonal Antibody PMab-231

  2019cites this paper
• Establishment of a monoclonal antibody PMab-225 against alpaca podoplanin for immunohistochemical analyses

  2019cites this paper
• Establishment of a monoclonal antibody PMab-233 for immunohistochemical analysis against Tasmanian devil podoplanin

  2019cites this paper
• Epitope Mapping of the Antihorse Podoplanin Monoclonal Antibody PMab-202

  2019cites this paper
• PMab-213: A Monoclonal Antibody for Immunohistochemical Analysis Against Pig Podoplanin

  2019cites this paper
• PMab-219: A monoclonal antibody for the immunohistochemical analysis of horse podoplanin

  2019cites this paper
• PMab-210: A Monoclonal Antibody Against Pig Podoplanin

  2019cites this paper
• Epitope Mapping of Monoclonal Antibody PMab-48 Against Dog Podoplanin

  2018cites this paper
• The role of podoplanin in cancer-associated thrombosis.

  2018cites this paper
• Establishment of Monoclonal Antibody PMab-202 Against Horse Podoplanin

  2018cites this paper
• Epitope Mapping of Monoclonal Antibody PMab-52 Against Cat Podoplanin

  2018cites this paper
• LpMab-23: A Cancer-Specific Monoclonal Antibody Against Human Podoplanin

  2017cites this paper
• PMab-52: Specific and Sensitive Monoclonal Antibody Against Cat Podoplanin for Immunohistochemistry

  2017cites this paper
• Development and validation of a cell-based fluorescent method for measuring antibody affinity.

  2017cites this paper
• Challenges and Recent Advances in Medulloblastoma Therapy.

  2017cites this paper
• ChLpMab-23: Cancer-Specific Human–Mouse Chimeric Anti-Podoplanin Antibody Exhibits Antitumor Activity via Antibody-Dependent Cellular Cytotoxicity

  2017cites this paper
• Recombinant Immunotoxin Therapy of Glioblastoma: Smart Design, Key Findings, and Specific Challenges

  2017cites this paper
• Selection of novel affinity-matured human chondroitin sulfate proteoglycan 4 antibody fragments by yeast display

  2017cites this paper
• Expression of Cat Podoplanin in Feline Squamous Cell Carcinomas

  2017cites this paper
• Antitumor activity of chLpMab‐2, a human–mouse chimeric cancer‐specific antihuman podoplanin antibody, via antibody‐dependent cellular cytotoxicity

  2017cites this paper
• Chimeric Anti-Human Podoplanin Antibody NZ-12 of Lambda Light Chain Exerts Higher Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity Compared with NZ-8 of Kappa Light Chain

  2017cites this paper
• Development and characterization of anti‐glycopeptide monoclonal antibodies against human podoplanin, using glycan‐deficient cell lines generated by CRISPR/Cas9 and TALEN

  2017cites this paper
• Antibody–drug conjugates in glioblastoma therapy: the right drugs to the right cells

  2017cites this paper
• Development of RAP Tag, a Novel Tagging System for Protein Detection and Purification

  2017cites this paper
• Epitope Mapping of Monoclonal Antibody PMab-38 Against Dog Podoplanin

  2017cites this paper
• Antiglycopeptide Mouse Monoclonal Antibody LpMab-21 Exerts Antitumor Activity Against Human Podoplanin Through Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity

  2017cites this paper
• Characterization of the Anti-Bovine Podoplanin Monoclonal Antibody PMab-44

  2017cites this paper
• Critical Epitope of Anti-Rabbit Podoplanin Monoclonal Antibodies for Immunohistochemical Analysis

  2016cites this paper
• PMab-44 Detects Bovine Podoplanin in Immunohistochemistry

  2016cites this paper
• LpMab-19 Recognizes Sialylated O-Glycan on Thr76 of Human Podoplanin

  2016cites this paper
• Novel Monoclonal Antibody LpMab-17 Developed by CasMab Technology Distinguishes Human Podoplanin from Monkey Podoplanin

  2016cites this paper
• SPECT imaging of neuropilin receptor type-1 expression with 131I-labeled monoclonal antibody.

  2016cites this paper
• Establishment of Novel Monoclonal Antibody PMab-32 Against Rabbit Podoplanin

  2016cites this paper
• PMab-38 Recognizes Canine Podoplanin of Squamous Cell Carcinomas

  2016cites this paper
• Specific Detection of Dog Podoplanin Expressed in Renal Glomerulus by a Novel Monoclonal Antibody PMab-38 in Immunohistochemistry

  2016cites this paper
• Establishment of Mouse Monoclonal Antibody LpMab-13 Against Human Podoplanin.

  2016cites this paper
• MAbs Against Bovine Podoplanin 1 PMab-44 Detects Bovine Podoplanin in Immunohistochemistry

  2016cites this paper
• Podoplanin Expression in Canine Melanoma

  2016cites this paper
• Establishment of Mouse Monoclonal Antibody LpMab-13 Against Human Podoplanin

  2016cites this paper
• CAR T Cells Targeting Podoplanin Reduce Orthotopic Glioblastomas in Mouse Brains

  2016cites this paper
• Antitumor effect of novel anti‐podoplanin antibody NZ‐12 against malignant pleural mesothelioma in an orthotopic xenograft model

  2016cites this paper
• LpMab-12 Established by CasMab Technology Specifically Detects Sialylated O-Glycan on Thr52 of Platelet Aggregation-Stimulating Domain of Human Podoplanin

  2016cites this paper
• The chimeric antibody chLpMab-7 targeting human podoplanin suppresses pulmonary metastasis via ADCC and CDC rather than via its neutralizing activity

  2015cites this paper
• Characterization of Monoclonal Antibody LpMab-3 Recognizing Sialylated Glycopeptide of Podoplanin

  2015cites this paper
• Anti-podoplanin Monoclonal Antibody LpMab-7 Detects Metastatic Lesions of Osteosarcoma

  2015cites this paper
• 1 An anti-podoplanin monoclonal antibody LpMab-7 detects metastatic legions of osteosarcoma

  2015cites this paper
• Contact Normalization or Escape from the Matrix

  2015cites this paper
• Development of Sensitive Monoclonal Antibody PMab-2 Against Rat Podoplanin

  2015cites this paper
• Monoclonal Antibody LpMab-9 Recognizes O-glycosylated N-Terminus of Human Podoplanin

  2015cites this paper
• Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms

  2015cites this paper
• PKA and CDK5 can phosphorylate specific serines on the intracellular domain of podoplanin (PDPN) to inhibit cell motility.

  2015cites this paper
• Podoplanin: A Marker for Reactive Gliosis in Gliomas and Brain Injury

  2015cites this paper
• Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis

  2015cites this paper
• Development of Monoclonal Antibody LpMab-10 Recognizing Non-glycosylated PLAG1/2 Domain Including Thr34 of Human Podoplanin

  2015cites this paper
• Characterization of Monoclonal Antibody LpMab-7 Recognizing Non-PLAG Domain of Podoplanin

  2015cites this paper
• The effect of podoplanin inhibition on lymphangiogenesis under pathological conditions.

  2014cites this paper
• A Cancer-specific Monoclonal Antibody Recognizes the Aberrantly Glycosylated Podoplanin

  2014cites this paper
• A platform of C-type lectin-like receptor CLEC-2 for binding O-glycosylated podoplanin and nonglycosylated rhodocytin.

  2014cites this paper
• Serines in the Intracellular Tail of Podoplanin (PDPN) Regulate Cell Motility*

  2013cites this paper
• A Novel Targeting Therapy of Malignant Mesothelioma Using Anti-Podoplanin Antibody

  2013cites this paper
• AntibodyMesothelioma Using Anti-Podoplanin A Novel Targeting Therapy of Malignant

  2013cites this paper
• Recombinant anti‐podoplanin (NZ‐1) immunotoxin for the treatment of malignant brain tumors

  2013cites this paper
• Radioimmunotherapy for high-grade glioma.

  2013cites this paper
• Toxin-Based Targeted Therapy for Malignant Brain Tumors

  2012cites this paper
• Chimeric anti‐podoplanin antibody suppresses tumor metastasis through neutralization and antibody‐dependent cellular cytotoxicity

  2012cites this paper
• SIB-DOTA: a trifunctional prosthetic group potentially amenable for multi-modal labeling that enhances tumor uptake of internalizing monoclonal antibodies.

  2012cites this paper
• Podoplanin expression in advanced atherosclerotic lesions of human aortas.

  2012cites this paper
• Editorial: The role of nuclear medicine in the management of patients with glioblastoma multiforme.

  2012cites this paper
• Plant Lectin Can Target Receptors Containing Sialic Acid, Exemplified by Podoplanin, to Inhibit Transformed Cell Growth and Migration

  2012cites this paper
• Regional Chemotherapy and Brachytherapy for Malignant Glioma – Clinical Experience and Serial Experiments

  2011cites this paper
• Development of Highly Sensitive Anti-Mouse CD39 Monoclonal Antibodies C 39 Mab-1 and C 39 Mab-2 for flow cytometry

  year unknowncites this paper
• Establishment of Anti-Dog PD-L1 Monoclonal Antibodies for Immunohistochemistry

  year unknowncites this paper